Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CRMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2010. Start Trial.
Date Value
June 30, 2026 77.67M
March 31, 2026 78.40M
December 31, 2025 79.26M
September 30, 2025 78.35M
June 30, 2025 74.62M
March 31, 2025 67.71M
December 31, 2024 64.41M
September 30, 2024 57.89M
June 30, 2024 55.27M
March 31, 2024 54.96M
December 31, 2023 54.94M
September 30, 2023 54.81M
June 30, 2023 45.81M
March 31, 2023 44.50M
December 31, 2022 42.82M
September 30, 2022 41.21M
June 30, 2022 41.11M
March 31, 2022 38.73M
December 31, 2021 38.09M
September 30, 2021 38.09M
June 30, 2021 38.09M
March 31, 2021 38.05M
December 31, 2020 33.56M
September 30, 2020 31.35M
June 30, 2020 26.13M
Date Value
March 31, 2020 26.13M
December 31, 2019 25.67M
September 30, 2019 25.65M
June 30, 2019 23.82M
March 31, 2019 23.81M
December 31, 2018 21.78M
September 30, 2018 19.77M
June 30, 2018 17.00M
March 31, 2018 16.36M
December 31, 2017 14.28M
September 30, 2017 12.40M
June 30, 2017 11.87M
March 31, 2017 8.144M
December 31, 2016 8.086M
September 30, 2016 8.081M
June 30, 2016 7.459M
March 31, 2016 7.228M
December 31, 2015 7.193M
September 30, 2015 7.075M
June 30, 2015 6.842M
March 31, 2015 5.573M
December 31, 2014 4.492M
September 30, 2014 4.465M
June 30, 2014 4.399M
March 31, 2014 4.399M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Innoviva, Inc. 72.64M
Zevra Therapeutics, Inc. 59.34M
Filana Therapeutics, Inc. 48.31M
Eloxx Pharmaceuticals, Inc. 4.036M
Cannabis Global, Inc. 6.564B